Administration of monoclonal antibodies against C5 and C5a as well as the C5a receptor reduced myocardial infarct size in pigs and rodents (Amsterdam et al. 1995; Vakeva et al. 1998; van der Pals et al. 2010; Zhang et al. 2007). This evidence concerns the gene C5 and myocardial infarction.